Your browser doesn't support javascript.
loading
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations.
Bigagli, Elisabetta; Luceri, Cristina; De Angioletti, Maria; Chegaev, Konstantin; D'Ambrosio, Mario; Riganti, Chiara; Gazzano, Elena; Saponara, Simona; Longini, Mariangela; Luceri, Francesca; Cinci, Lorenzo.
Afiliação
  • Bigagli E; Department of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.
  • Luceri C; Department of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.
  • De Angioletti M; Cancer Genetics and Gene Transfer Laboratory, Core Research Laboratory, Istituto Toscano Tumori, Florence, Italy.
  • Chegaev K; Institute of Chemistry of Organometallic Compounds, CNR, Sesto Fiorentino, Florence, Italy.
  • D'Ambrosio M; Department of Drug Science and Technology, University of Turin, Turin, Italy.
  • Riganti C; Department of Neuroscience, Psychology, Drug Research and Child Health - NEUROFARBA - Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.
  • Gazzano E; Department of Oncology, University of Turin, Turin, Italy.
  • Saponara S; Department of Oncology, University of Turin, Turin, Italy.
  • Longini M; Department of Life Sciences, University of Siena, Siena, Italy.
  • Luceri F; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Cinci L; General Laboratory Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Invest New Drugs ; 36(6): 985-998, 2018 12.
Article em En | MEDLINE | ID: mdl-29607467
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Resistencia a Medicamentos Antineoplásicos / Terapia de Alvo Molecular / Neoplasias de Próstata Resistentes à Castração / Sulfeto de Hidrogênio / Óxido Nítrico Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Resistencia a Medicamentos Antineoplásicos / Terapia de Alvo Molecular / Neoplasias de Próstata Resistentes à Castração / Sulfeto de Hidrogênio / Óxido Nítrico Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article